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Abstract
BACKGROUND: The aging process can increase the incidence of dementia, such as spatial memory impairment to 
remember space, recognize shapes and distances. Research on dementia in mice was carried out by administering 
d-galactose through intraperitoneal injection,  while oral d-galactose administration had not received enough attention. 
AIM: This study aims to prove the differences in the occurrence of spatial memory impairment in rats induced by 
d-galactose through two different routes, oral and intraperitoneal injection. 
METHODS: This study is an experimental study using a post- test control group design. The sample criteria 
were 20 male Wistar rats aged 12–14 weeks, weighing 200–300 g divided into two groups which are the oral and 
intraperitoneal injection. Spatial memory assessment based on spontaneous alternation using the Y-maze test was 
carried out at the end of week 8. 
RESULTS: In this study, the average spatial memory score after d-galactose administration in the injection group 
(51.572±4.388) was lower compared to the oral group (66.058±1.551). The Shapiro–Wilk normality test shows that 
the data are normally distributed with p > 0.05. Independent t-test showed a significant difference in the incidence 
of spatial memory disorders between the injection and oral groups with p = 0.010 (p < 0.05). 
CONCLUSION: The conclusion of this study is that d-galactose administration by oral route or intraperitoneal 
injection causes a decrease in spatial memory in mice. Spatial memory in the injection group was lower than in the 
oral group. This might be related to the decrease in synaptophysin in the hippocampus of mice due to d-galactose 
administration by intraperitoneal injection.
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Introduction
The aging process causes progressive 
deterioration in tissues and organs, accompanied by 
an increased incidence of neurodegenerative diseases 
such as dementia. Dementia is characterized by a 
gradual loss of cognitive performance, memory, and 
spatial ability [1]. The main characteristic of Alzheimer’s 
dementia (AD) is cognitive impairment related to disorders 
of the hippocampus for the storage of spatial memory and 
emotional behavior. Spatial memory in animals is related 
to the ability to remember space, recognize shapes and 
distances that play a role in finding locations, where 
food is available and safety in sustaining life [2]. The 
Y-maze test was developed to assess working memory 
based on spatial learning by assessing the activity of 
mice in exploring new environments and looking for 
food quickly and efficient [3]. It is useful for assessing 
memory skills, which depend on the function of various 
areas of the brain, especially the hippocampus, septum, 
basal forebrain, and prefrontal cortex [4].
D-galactose induces advanced glycation end 
products (AGEs) and reactive oxygen species that cause 
mitochondrial dysfunction, oxidative stress, inflammation, 
and apoptosis in nerve cells [5], so d-galactose can be 
used as a model for aging in AD and other memory 
impaired. Brain aging induced by d-galactose is highly dose 
dependent, starting from 100 mg/kg/day to 500 mg/kg/day 
with the administration for 6–8 weeks [6]. Most studies in 
the accessible literature state that d-galactose can be 
used for mice with dementia models when administered 
by subcutaneous or intraperitoneal injection. However, 
several studies have shown that oral administration of 
d-galactose also causes age-related changes [7].
There are many studies of dementia model 
mice with a focus on d-galactose administration through 
intraperitoneal and subcutaneous injection, whereas 
oral d-galactose administration has not received 
enough attention [8]. Most authors mention that chronic 
administration of d-galactose can cause learning and 
memory impairment in mice, while the acute effect of 
d-galactose administration is unclear [7]. Hence, this 
study is planned to evaluate the impacts of d-galactose 
induction in Wistar rats through two different routes that 
are intraperitoneal injection and oral administration of 
spatial memory using the Y-maze test.
Methods and Procedures
This research is an experimental study with a 
post-test control group design research. Male Wistar rats 
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aged 12–14 weeks weighing 200–300 g were kept in the 
Animal Laboratory Unit of the Pharmacology Unit of the 
Faculty of Medicine, Udayana University. The study was 
conducted for 8 weeks from June to August 2019. The 
subjects were 20 rats divided into two groups of 10 rats 
each as an oral group who received the oral d-galactose 
and 10 rats as an injection group who received the 
intraperitoneal d-galactose injection. Induction of 
d-galactose at a dose of 100 mg/kg/day orally through 
a nasogastric tube once every day at 08.00 am and 
intraperitoneal injection induction is done every day 
by changing the side of the injection between the right 
and left. The Wistar rat was conducted according to the 
policy of research ethics with ethical clearance (No.1799/
UN14.2.2.VII.14/LP/2019) from the ethical commission 
at the Faculty of Medicine, Udayana University. Spatial 
memory assessment based on spontaneous alternation 
using the Y-maze test measured for 5 min and recorded 
using video. Y-maze test was carried out in a closed and 
quiet room in both groups at the end of week 8. Spatial 
memory is expressed by spontaneous alternation (%) 
when mice can enter three different arms sequentially 
according to the overlapping set of triplets.
Results and Discussion
Results of mean spatial memory scores in this 
study after d-galactose administration in the injection 
group (51.572 ± 4.388) were lower than those in the oral 
group (66.058 ± 1.551). The Shapiro–Wilk normality 
test shows that the data are normally distributed with 
p > 0.05. An independent t-test was used to assess 
the differences in spatial memory scores between the 
oral and injection groups after the administration of 
d-galactose. Independent t-test obtained a significant 
difference in the incidence of spatial memory impairment 
between the injection and oral groups with p = 0.010 
(p < 0.05). The analysis results are presented in Table 1.
Table 1: Mean spatial memory scores after d-galactose 
administration
Group Mean spatial memory scores p
Oral 66.058 ± 1.551 0.010
Injection 51.572 ± 4.388
Chronic administration of d-galactose, 
regardless of the route, is used as a model of cognitive 
impairment and aging. The development of aging is 
characterized by a gradual loss of cognitive performance, 
memory, and spatial ability [1]. In this study, it was found 
that d-galactose administration caused a decrease in 
spatial memory in both oral and injection groups. The 
results obtained in this study are similar to studies 
conducted by Cardoso et al. that systemic exposure 
to d-galactose results in biochemical changes and 
morphological aging in several organs, including the 
central nervous system. Exposure to d-galactose can 
shorten lifespan and cause behavioral changes such 
as learning and memory disorders and other cognitive 
declines [9]. Giving d-galactose can be used as a model 
of aging that is fast, economical, and widely used for 
anti-aging pharmacological research. Other advantages 
are its easy application, low tumor incidence, and high 
animal survival rate during the study period [9].
The mean spatial memory score in this study after 
administration of d-galactose in the injection group (51.572 
± 4.388) was lower than the oral group (66.058 ± 1.551). 
Lin et al. suggested that the administration of d-galactose 
by intraperitoneal injection significantly increased the Aβ 
level in rat hippocampus. The previous study also stated 
that the administration of d-galactose by intraperitoneal 
injection could raise the aggregation and deposition of 
Aβ in the brain, and this process subsequently leads to a 
cellular cascade of neuronal loss and dementia [8], while 
other evidence suggests that oral administration of 
d-galactose can have a protective effect on AD animal 
models induced by streptozotocin. A study comparing 
chronic systemic administration of d-galactose with oral 
results shows that the route of oral administration can 
improve cognitive deficits in streptozotocin-induced AD 
models in mice, where the protective effect of d-galactose 
depends on the concentration or route of administration. 
Hence, there is still controversy surrounding the use of 
d-galactose through this route orally [7].
The difference in the occurrence of spatial 
memory impairment between the injection and oral groups 
in this study was assessed using an independent t-test 
obtained p = 0.010 (p < 0.05). The results of this study can 
be concluded that there are significant differences in the 
incidence of spatial memory impairment in rats induced 
by oral d-galactose and intraperitoneal injection. Spatial 
memory in the injection group was lower than in the oral 
group. One study also observed that synaptophysin 
(one of the main protein components in synaptic 
vesicles responsible for neuron transmission) is reduced 
in elderly individuals with cognitive impairment and 
dementia, suggesting that synaptic loss is a significant 
contributor to dementia in the elderly. Another study 
showed that d-galactose 120 mg/kg/day for 60 days, 
administered intraperitoneally, could induce a decrease 
of synaptophysin in rat hippocampus, in contrast, 
d-galactose given orally did not change synaptophysin 
after 4 or 6 weeks of treatment [8].
Galactose has protecting effect to cholinergic 
neurons during hypoglycemia conditions at low 
pH levels (pH 6.7–6.9) to maintain brain function 
under hypometabolism [10]. Prolonged d-galactose 
administration could interfere with the body’s natural 
ability to convert galactose to glucose, causing an 
increase in galactitol and aldose reductase activation, 
resulting in oxidative damage to cells and forms AGE. The 
previous studies have shown that chronic administration 
of d-galactose injected through the intraperitoneal route 
at a dose of 100 mg/kg induces cognitive impairment after 
8 or 12 weeks of administration. In our study, d-galactose 
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administered through the oral route also produced memory 
deficits in mice, suggesting that continuous administration 
by the oral route can cause interference with behavior. 
The oral route can minimize stress levels and damage 
due to carbohydrate administration compared to using 
the intraperitoneal route for an extended period [8].
Conclusion
Based on the results of this study, it was 
concluded that there were differences in the incidence 
of spatial memory disorders in rats induced by oral 
d-galactose and intraperitoneal injection. Spatial 
memory impairment appears to be lower in d-galactose 
by intraperitoneal injection than oral administration. This 
might be related to the decrease in synaptophysin in the 
hippocampus of mice due to d-galactose administration 
by intraperitoneal injection.
Further research needs to be done to understand 
the effects of oral d-galactose administration in rats with 
a longer time to ascertain spatial memory disorders that 
have occurred and clarify their therapeutic potential as well 
as subsequent studies using antioxidants in d-galactose-
induced mice to observe improvements in spatial memory.
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